Sao Paulo starts building production plant for China's Sinovac vaccine: governor

SAO PAULO (Reuters) - The Brazilian state of São Paulo has begun building a facility to produce 100 million doses a year of China's Sinovac vaccine against COVID-19, which will be ready by September next year, Governor João Doria said on Monday.

Reuters November 10, 2020 00:11:51 IST
Sao Paulo starts building production plant for China's Sinovac vaccine: governor

Sao Paulo starts building production plant for Chinas Sinovac vaccine governor

SAO PAULO (Reuters) - The Brazilian state of São Paulo has begun building a facility to produce 100 million doses a year of China's Sinovac vaccine against COVID-19 , which will be ready by September next year, Governor João Doria said on Monday.

Sao Paulo is also importing the vaccine before the facility is ready and Doria said the first batch of 120,000 imported Sinovac vaccines will arrive on Nov. 20 with the state's Butantan biomedical center receiving a total of 6 million doses by year-end.

The vaccine production facility will cost 142 million reais ($26.5 million), which will be donated by private companies.

The Butantan Institute will soon publish results from clinical Phase III tests it has conducted in Brazil to demonstrate the safety and efficacy of Sinovac's vaccine, Sao Paulo Health Secretary Jean Gorinchteyn said.

He said previous studies have established the safety of the vaccine known as CoronaVac and shown it produces antibodies in almost 98% of the volunteers that received the shots.

Doria said the vaccine will only be used once it has been approved by Brazil's health regulator, Anvisa.

(Reporting by Eduardo Simoes and Anthony Boadle in Sao Paulo; Editing by Stephen Eisenhammer and Matthew Lewis)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

U.S. data suggest economic recovery may be weakening
Business

U.S. data suggest economic recovery may be weakening

By Howard Schneider WASHINGTON (Reuters) - The explosive surge in U.S. coronavirus cases this fall has left a question hanging: When will the economy take its own turn for the worse

Fed, ECB heads give COVID-19 vaccine cautious welcome
Business

Fed, ECB heads give COVID-19 vaccine cautious welcome

FRANKFURT/WASHINGTON (Reuters) - The heads of the Federal Reserve and the European Central Bank welcomed the encouraging results in trials of a vaccine candidate for the novel coronavirus but stressed that the economic outlook will remain uncertain. Fed chair Jay Powell and ECB President Christine Lagarde said the economy was still in for a tough time even if the development of a potential vaccine by U.S. drugmaker Pfizer and German partner BioNTech SE was reason for some optimism further ahead

India's October fuel demand marks first year-on-year gain in 8 months
Business

India's October fuel demand marks first year-on-year gain in 8 months

By Sumita Layek (Reuters) - India's fuel consumption in October registered its first year-on-year increase since February, as slowing coronavirus cases and increased mobility accelerated an economic recovery, data showed on Thursday.